Simulations Plus

Simulations Plus Payout Ratio

Delisted·Oct 7, 2026

The Dividend Payout Ratio of Simulations Plus (SLP) as of Nov 11, 2026 is 36.65 %. In the previous year, Dividend Payout Ratio was 48.86 % — a change of -25.00% (lower).

Payout Ratio

36.65 %

YoY

-25.00%

Last updated:

Dividend Payout Ratio of Simulations Plus is 2024 36.65 % . Dividend Payout Ratio of Simulations Plus was 2023 48.86 % . It decreases by -25.00% lower compared to the previous year.

The payout ratio is around 37% of earnings.

The Simulations Plus Payout Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Payout Ratio
Date
Payout Ratio
Jan 1, 2023
48.86 USD
Jan 1, 2024
36.65 USD
Jan 1, 2025
41.85 USD
Jan 1, 2026 (e)
29.27 USD
Jan 1, 2027 (e)
27.12 USD
Jan 1, 2028 (e)
22.64 USD
Jan 1, 2029 (e)
18.75 USD
Jan 1, 2030 (e)
15.38 USD
The Simulations Plus Payout Ratio history
YEARPayout RatioYoY
est15.38 %-17.95%
est18.75 %-17.19%
est22.64 %-16.51%
est27.12 %-7.34%
est29.27 %-30.06%
41.85 %+14.19%
36.65 %-25.00%
48.86 %+22.03%
40.04 %-21.34%
50.90 %-4.84%
53.49 %+4.49%
51.19 %+5.89%
48.34 %-25.40%
64.80 %-7.87%
70.34 %-21.67%
89.80 %-36.44%
141.28 %+149.18%
56.70 %-69.15%
183.77 %+339.13%
41.85 %0.00%
41.85 %0.00%
41.85 %0.00%
41.85 %0.00%
41.85 %0.00%
41.85 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Simulations Plus Stock analysis

What does Simulations Plus do? Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Simulations Plus stock

Dividend Payout Ratio of Simulations Plus is 36.65 % in 2024.

Dividend Payout Ratio of Simulations Plus changed from 48.86 % to 36.65 %, representing a -25.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Payout Ratio Simulations Plus since 2006 – with annual values, charts, and detailed analysis.

The payout ratio measures the percentage of net income distributed as dividends. A sustainable payout ratio leaves room for reinvestment and growth.

Dividend Payout Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Payout Ratio's Simulations Plus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Simulations Plus

All Key Metrics — Simulations Plus